Opportunities for prevention: Hepatitis C prevalence and incidence in a cohort of young injection drug users
Open Access
- 1 September 2002
- journal article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 36 (3) , 737-742
- https://doi.org/10.1053/jhep.2002.35065
Abstract
The objective of this study was to compare sociodemographic, drug, and sexual risk characteristics between hepatitis C virus (HCV) baseline positive and negative young (13-24 years) injection drug users (IDUs) and to determine prospective risk factors for HCV seroconversion among the youth. Data were collected through the Vancouver Injection Drug Users Study (VIDUS). To date, more than 1,400 Vancouver-area IDUs have been enrolled and followed up; 234 were aged 24 years and younger. Semiannually, participants have completed an interviewer-administered questionnaire and have undergone serologic testing for human immunodeficiency virus (HIV) and HCV. Univariate and multivariate logistic regression analyses were undertaken to investigate predictors of baseline HCV positivity. In the multivariate analyses, Cox regression models with time-dependent covariates were used to identify predictors of HCV seroconversion. Of the 232 young injectors, 107 (46%) were HCV positive at baseline and a further 37 HCV seroconverted during the study period for an incidence rate of 37.3 per 100 person-years. Baseline positivity was associated with Aboriginal ancestry, older age, greater number of years injecting drugs, recent incarceration, sex trade work, more than 100 lifetime sexual partners, a previous sexually transmitted disease, living in the IDU epicenter, and injection more than once per day of heroin, cocaine, and speedball. Factors independently associated with HCV seroconversion were having a partner who uses injection drugs, requiring help to inject, and injection of cocaine more than once daily. In conclusion, unlike older IDUs, more than one half of young injectors were HCV negative at recruitment. Thus, there is a window of opportunity for prevention. However, the incidence rate of HCV among these young IDUs is alarming, suggesting that the opportunity to intervene is exceedingly small.Keywords
This publication has 23 references indexed in Scilit:
- Public Health and Changes in Illicit Drug PricesAmerican Journal of Public Health, 2001
- Hepatitis C Virus Infection and Needle Exchange Use Among Young Injection Drug Users in San FranciscoHepatology, 2001
- Hepatitis C Virus Infection: Prevalence, Risk Factors, and Prevention Opportunities among Young Injection Drug Users in Chicago, 1997–1999The Journal of Infectious Diseases, 2000
- Correlates of HIV infection among young adult short-term injection drug usersAIDS, 2000
- The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994New England Journal of Medicine, 1999
- Continuing injecting risk behaviour: results from the Amsterdam Cohort Study of drug usersAddiction, 1999
- Prevalence and incidence rate of HIV, hepatitis B and C among drug users on methadone maintenance treatment in Geneva between 1988 and 1995AIDS, 1998
- Prevalence and Incidence of Hepatitis C Virus Infection Among Young Adult Injection Drug UsersJAIDS Journal of Acquired Immune Deficiency Syndromes, 1998
- Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses.American Journal of Public Health, 1996
- Hepatitis C virus infection in Italian intravenous drug users: epidemiological and clinical aspectsLiver International, 1995